RH5.1

RH5.1 malaria antigen · University of Oxford

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RH5.1, covering 2025-04-01 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M [Phase 2]

See pricing